menu
    • menu

    Company profile for Escient Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. We are focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-infl...
    We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. We are focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-inflammatory and autoreactive diseases. Based in San Diego, we are led by an experienced team of entrepreneurs with deep roots in this region’s life sciences ecosystem and specific expertise in GPCR drug discovery etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Escient PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10578 Science Center Drive Suite 250 San Diego, CA 92121
    Telephone
    Telephone
    858.617.8220
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.escientpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/escientpharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Incyte’s $750M buyout rocked by pause on key trial, asset cull
    Incyte’s $750M buyout rocked by pause on key trial, asset cull

    18 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/incytes-750m-buyout-rocked-pause-key-trial-asset-cull

    FIERCE BIOTECH
    18 Nov 2024
    Share Share
    Incyte Completes Acquisition of Escient Pharmaceuticals
    Incyte Completes Acquisition of Escient Pharmaceuticals

    30 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240530903016/en

    BUSINESSWIRE
    30 May 2024
    Share Share
    Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
    Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists

    24 Apr 2024

    // PRESS RELEASE

    https://www.escientpharma.com/incyte-announces-acquisition-of-escient-pharmaceuticals-and-its-pipeline-of-first-in-class-oral-mrgpr-antagonists/

    PRESS RELEASE
    24 Apr 2024
    Share Share
    Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262
    Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262

    28 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231128952879/en

    BUSINESSWIRE
    28 Nov 2023
    Share Share
    Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262
    Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262

    12 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231012868795/en

    BUSINESSWIRE
    12 Oct 2023
    Share Share
    Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262
    Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262

    25 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230925421447/en

    BUSINESSWIRE
    25 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search